Fig. 1From: CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancerImmunohistochemical staining for CMTM1_v17. a, b The low expression of CMTM1_v17 in non-small cell lung cancer (NSCLC) primary tumor; (c, d) The high expression of CMTM1_v17 in NSCLC primary tumor; the magnification was ×200Back to article page